699810P

PHAD^™-504

Avanti Research^™ - A Croda Brand

• Synonim(y): Monophosphoryl Lipid A-504
• Wzór empiryczny (zapis Hilla): C₉₄H₁₈₀ N₃O₂₂P
• Numer CAS: 1332714-01-8
• Masa cząsteczkowa: 1735.42
• Kod UNSPSC: 12352211
• NACRES: NA.25

Właściwości

• Próba: >99% (HPLC)
• Postać: powder
• opakowanie: pkg of 1 × 1 mg (699810P-1mg); pkg of 1 × 5 mg (699810P-5mg)
• producent / nazwa handlowa: Avanti Research^™ - A Croda Brand
• Zastosowanie: vaccine development
• Warunki transportu: dry ice
• temp. przechowywania: −20°C

Opis

Opis ogólny

PHAD^™-504 was designed as a synthetic structural analog of detoxified monophosphoryl lipid A (MPLA) derived from E. coli lipopolysaccharide (LPS). It is structurally similar to PHAD^™, differing only in the length of a single fatty acid chain. As expected, the activity of PHAD^™-504 is quite similar to that of PHAD^™, making the two products interchangeable as adjuvants in vaccine or immunotherapy formulations.

Opakowanie

2 mL Amber Glass Crimp Cap Vial (699810P-1mg)

2 mL Amber Glass Crimp Cap Vial (699810P-5mg)

Inne uwagi

For R&D use only. Not for drug, household, or other uses.

Informacje prawne

Avanti Research is a trademark of Avanti Polar Lipids, LLC

PHAD is a trademark of Avanti Polar Lipids, LLC

This page may contain text that has been machine translated.

Informacja o środkach bezpieczeństwa

• Kod klasy składowania: 11 - Combustible Solids
• Klasa zagrożenia wodnego (WGK): WGK 3
• Temperatura zapłonu (°F): No data available
• Temperatura zapłonu (°C): No data available